RENO, Nev.--(BUSINESS WIRE)--Lifeline Biotechnologies, Inc. (OTCPK:LLBT), a developer of innovative medical technology, today announced that CEO, Jim Holmes, was interviewed on www.stockbully.com. In the interview, Mr. Holmes discussed the current status of the Company’s patented First Warning System™, a technology that could assist in the early, non-invasive detection of breast cancer.
